Nutrien Q3 Profit Falls 39% as Retail Guidance Cut; White Springs to Close
NTR sits 36% above its 52-week low of $53.03.
Summary
Nutrien's Q3 net earnings dropped to $288 million ($0.60 per diluted share) from $469 million a year earlier, and adjusted EBITDA fell 8% to $1.31 billion. The miss was concentrated in Phosphate, where adjusted EBITDA collapsed 93% to $8 million on higher sulfur costs, and Nitrogen, down 11% to $497 million on lower volumes. Management cut full-year Retail adjusted EBITDA guidance to $1.72-$1.85 billion from $1.75-$1.95 billion, citing weaker crop nutrient margins, and lowered phosphate volume guidance to 2.40-2.55 million tonnes. The bigger news is the phosphate strategic review outcome: Nutrien rejected non-binding bids for the business, will keep Aurora, and will shut the White Springs facility in Q2 2027 — a move expected to cut annual sustaining capex and lease payments by about $50 million. White Springs carries $430 million of assets to be assessed for impairment, and the already-announced Trinidad shutdown adds $760 million, with both impairments landing in Q4. Potash was the bright spot, with nine-month adjusted EBITDA up 9% to $1.97 billion on record volumes and 2026 potash volume guidance raised to 14.3-14.8 million tonnes; 2026 nitrogen volume guidance was raised to 9.3-9.7 million tonnes and capital expenditure guidance lowered to $1.95-$2.00 billion. The Q3 earnings call is November 5 at 10:00 a.m. ET.
Updated with an SEC 6-K filing · What changed
Updates
· SEC 6-K — Nutrien raised 2026 potash volume guidance to 14.3-14.8 million tonnes and nitrogen to 9.3-9.7 million tonnes, and lowered capital expenditure guidance to $1.95-$2.00 billion.
At the time of this announcement, NTR was trading at $72.07 on NYSE in the Manufacturing sector, with a market capitalization of approximately $34.3B. The 52-week trading range was $53.03 to $85.36. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: BusinessWire.